OGN
Price
$14.66
Change
-$0.04 (-0.27%)
Updated
Dec 24, 10:51 AM (EDT)
51 days until earnings call
VRBCF
Price
$339.23
Change
-$42.77 (-11.20%)
Updated
Dec 12 closing price
Ad is loading...

OGN vs VRBCF

Header iconOGN vs VRBCF Comparison
Open Charts OGN vs VRBCFBanner chart's image
Organon & Co
Price$14.66
Change-$0.04 (-0.27%)
Volume$1.52K
CapitalizationN/A
Virbac SA
Price$339.23
Change-$42.77 (-11.20%)
Volume$23
CapitalizationN/A
OGN vs VRBCF Comparison Chart
Loading...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OGN vs. VRBCF commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGN is a Hold and VRBCF is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 24, 2024
Stock price -- (OGN: $14.70 vs. VRBCF: $339.23)
Brand notoriety: OGN and VRBCF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OGN: 119% vs. VRBCF: 51%
Market capitalization -- OGN: $4.73B vs. VRBCF: $2.61B
OGN [@Pharmaceuticals: Major] is valued at $4.73B. VRBCF’s [@Pharmaceuticals: Major] market capitalization is $2.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGN’s FA Score shows that 2 FA rating(s) are green whileVRBCF’s FA Score has 0 green FA rating(s).

  • OGN’s FA Score: 2 green, 3 red.
  • VRBCF’s FA Score: 0 green, 5 red.
According to our system of comparison, VRBCF is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 4 TA indicator(s) are bullish while VRBCF’s TA Score has 1 bullish TA indicator(s).

  • OGN’s TA Score: 4 bullish, 4 bearish.
  • VRBCF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, both OGN and VRBCF are a good buy in the short-term.

Price Growth

OGN (@Pharmaceuticals: Major) experienced а +0.82% price change this week, while VRBCF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.93%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was -2.87%.

Reported Earning Dates

OGN is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.93% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OGN($4.73B) has a higher market cap than VRBCF($2.61B). VRBCF has higher P/E ratio than OGN: VRBCF (29.33) vs OGN (4.64). VRBCF YTD gains are higher at: 17.788 vs. OGN (8.295). OGN has higher annual earnings (EBITDA): 1.44B vs. VRBCF (213M). OGN has more cash in the bank: 693M vs. VRBCF (176M). VRBCF has less debt than OGN: VRBCF (148M) vs OGN (8.76B). OGN has higher revenues than VRBCF: OGN (6.26B) vs VRBCF (1.15B).
OGNVRBCFOGN / VRBCF
Capitalization4.73B2.61B181%
EBITDA1.44B213M674%
Gain YTD8.29517.78847%
P/E Ratio4.6429.3316%
Revenue6.26B1.15B544%
Total Cash693M176M394%
Total Debt8.76B148M5,919%
FUNDAMENTALS RATINGS
VRBCF: Fundamental Ratings
VRBCF
OUTLOOK RATING
1..100
99
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGNVRBCF
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
11%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
14%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
68%
N/A
Advances
ODDS (%)
Bullish Trend 1 day ago
67%
N/A
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
69%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
20%
View a ticker or compare two or three
Ad is loading...
OGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRBCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IPAC60.760.49
+0.81%
iShares Core MSCI Pacific ETF
LRGE76.980.59
+0.77%
ClearBridge Large Cap Growth ESG ETF
BBSB98.14N/A
N/A
JPMorgan BetaBuilders U.S. TrsBd1-3YrETF
OWNS16.97-0.05
-0.27%
CCM Affordable Housing MBS ETF
KURE14.33-0.10
-0.69%
KraneShares MSCI All China Hlth Care ETF

VRBCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRBCF has been loosely correlated with RCDTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if VRBCF jumps, then RCDTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRBCF
1D Price
Change %
VRBCF100%
N/A
RCDTF - VRBCF
56%
Loosely correlated
N/A
OGN - VRBCF
1%
Poorly correlated
+0.82%
MIRA - VRBCF
1%
Poorly correlated
-0.94%
CSWYF - VRBCF
0%
Poorly correlated
N/A
JCRRF - VRBCF
-0%
Poorly correlated
N/A
More